New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Novatek Pharmaceuticals, Inc.
www.novatekpharmceuticals.com · DE · Filed Dec 21, 2022
Novatek Pharmaceuticals, Inc. filed a Form C — new offering — with the SEC on Dec 21, 2022. The Regulation Crowdfunding offering seeks $50,000, up to a maximum of $5,000,000 on Deal Maker. Investors receive: Common Stock at $2.00. The offering closes 12-14-2023.
| Target raise | $50,000 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Common Stock @ $2.00 |
| Closes | 12-14-2023 |
| Portal | Deal Maker |
Filing documents
FORM C
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.
SuperCrowd